United Drug (UDG)

Advertisement

Just one of over 6000 shares you can deal on with IG. Find out more by getting your free guide to spread betting on shares. Losses can exceed your initial deposit

329.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 340.00
  • 52 Week Low: 158.50
  • Currency: UK Pounds
  • Shares Issued: 240.20m
  • Volume: 91,209
  • Market Cap: £791.45m
  • RiskGrade: 158
  • Beta: 0.33

United Drug Overview

United Drug is in the food & drug retailers sector and is currently trading at 329.50p per share. In the last year United Drug's share price has ranged from 158.50p to 340.00p and brokers are currently rating this stock as 'buy'.

1 Day Chart (20-05-2013)

6 Month Chart

Financials

Latest F'cast
Div Yield 2.3% 2.4%
Div Cover 2.8 2.9
Op Mrgn 3.4% 3.3%
ROCE 18.5%  
Latest F'cast
P/E 15.3 14.3
PEG 1.4 2.1
Pr/Revenue 0.5 0.5
Pr/Book 2.2  
Latest F'cast
Revenue 4.8% -21.0%
PBT 33.6% -18.4%
EPS 11.2% 6.8%
DPS 4.4% -25.6%

United Drug Fundamentals

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-08 1,683.71 58.55 25.93¢ 13.3 1.1 +12% 8.00¢ 2.3%
30-Sep-09 1,717.94 39.15 23.45¢ 10.4 n/a -10% 8.00¢ 3.3%
30-Sep-10 1,726.07 54.44 22.84¢ 11.2 n/a -3% 8.40¢ 3.3%
30-Sep-11 1,746.45 44.17 22.89¢ 10.3 n/a 0% 8.66¢ 3.7%
30-Sep-12 1,830.21 58.99 25.46¢ 11.1 1.0 +11% 9.04¢ 3.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

United Drug Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-13 1,710.41 56.93 23.00p 14.3 2.1 +7% 7.96p 2.4%
30-Sep-14 1,753.37 71.26 25.35p 13.0 1.3 +10% 8.40p 2.6%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

United Drug Company Announcements

Director/PDMR Shareholding 20-May-2013 10:23 RNS
Director/PDMR Shareholding 14-May-2013 17:13 RNS
Half Yearly Report 09-May-2013 07:00 RNS

United Drug ShareCast News

Unilever director builds stake 20-May-2013 ShareCast
Monday broker round-up UPDATE 20-May-2013 ShareCast
United Drug delivers solid first half results 09-May-2013 ShareCast

United Drug Top Newspaper Links

Director Dealings: Hyder seeks cost cuts 22-Feb-2009 Scotland on Sunday
Need to know: TNK-BP resolves dispute ... Tata r... 04-Oct-2008 Times
BAA pushes for more strike talks 31-Dec-2007 Guardian

Latest United Drug Director Deals

Traded Action Notifier PriceAmountValue
17-May-13 Sell Chris Corbin 327.00p 56,000 £183,120.00
17-May-13 Exercise of option Chris Corbin 168.30p 56,000 £94,250.43
28-Feb-13 Buy Dividends Barry McGrane 286.81p 13,435 £38,532.60

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

United Drug Market Data

Currency UK Pounds
Share Price 329.50p
Change Today 0.50p
% Change 0.15 %
52 Week High 340.00
52 Week Low 158.50
Volume 91,209
Shares Issued 240.20m
Market Cap £791.45m
Beta 0.33
RiskGrade 158

United Drug Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.35% below the market average91.35% below the market average91.35% below the market average91.35% below the market average91.35% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average
Price Trend
84.43% above the market average84.43% above the market average84.43% above the market average84.43% above the market average84.43% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Income
46.83% below the market average46.83% below the market average46.83% below the market average46.83% below the market average46.83% below the market average
7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average7.69% below the sector average
Growth
53.27% below the market average53.27% below the market average53.27% below the market average53.27% below the market average53.27% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 1
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

United Drug Dividends

  Latest Previous
  Interim Final
Ex-Div 15-May-13 21-Nov-12
Paid 16-Jul-13 25-Feb-13
Amount 2.61¢ 6.56¢

Trades for 20-May-2013

Time Volume / Share Price
16:40 448 @ 327.11p
16:35 2,660 @ 329.50p
16:29 3 @ 329.90p
16:29 100 @ 329.90p
16:22 572 @ 328.73p

United Drug Key Personnel

CEO Liam FitzGerald
Finance Director Barry McGrane

Top of Page